supp.fit

Astragalus: study protocols

22 study groups say how much Astragalus participants took a day. These are the doses the studies gave. They are not a recommendation.

Astragalus: what the research found →

Dose per serving from products

253 products in our catalogue print how much Astragalus a serving holds.

Most common: 25 mg to 50 mg, 23% of 253 products.

Dose per servingProducts
10 mg or less
7
10 mg to 25 mg
24
25 mg to 50 mg
58
50 mg to 100 mg
47
100 mg to 250 mg
46
250 mg to 500 mg
24
500 mg to 1 g
22
1 g to 2.5 g
24
over 2.5 g
1

Dose per serving from research

21 study groups in 16 studies say how much Astragalus participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 5 g to 10 g, 29% of 21 study groups.

Daily doseStudy groups
10 mg or less
1
10 mg to 25 mg
1
25 mg to 50 mg
0
50 mg to 100 mg
0
100 mg to 250 mg
0
250 mg to 500 mg
1
500 mg to 1 g
3
1 g to 2.5 g
0
2.5 g to 5 g
4
5 g to 10 g
6
10 g to 25 g
3
25 g to 50 g
2

Commonly used together

4 of 22 study groups took Astragalus with something else, but nothing that 3 or more different studies gave.

22 study groups

Study
SHPro(®) (mixture of Angelica gigas and Astragalus membranaceus) in men with lower urinary tract symptoms: A randomized, double-blind, placebo-controlled clinical trial
2025 · Treatment group · Men aged 40–75 with lower urinary tract symptoms and an International Prostate Symptom Score of 8–19
600 mg12 weeks50
Chronic fatigue syndrome post-COVID-19: triple-blind randomised clinical trial of Astragalus root extract
2025 · intervention group · Nurses with post-COVID-19 chronic fatigue syndrome
1 g—32
[Treatment of leucopenia with pure Astragalus preparation--an analysis of 115 leucopenic cases]
1995 · Group I (more concentrated PAP) · Patients with leucopenia; age and sex not specified
30 g8 weeks58
[Treatment of leucopenia with pure Astragalus preparation--an analysis of 115 leucopenic cases]
1995 · Group II (less concentrated PAP) · Patients with leucopenia; age and sex not specified
10 g8 weeks57
Effects of the traditional Chinese herb Astragalus membranaceus in patients with poststroke fatigue: A double-blind, randomized, controlled preliminary study
2016 · treatment group (TG) · Patients with poststroke fatigue
8.4 g4 weeks31
Clinical effect of Astragalus granule of different dosages on quality of life in patients with chronic heart failure
2011 · high dosage · Patients with chronic heart failure and Fei-qi-deficiency and/or Xin-Shen yang-deficiency syndromes
15 g30 days30
Clinical effect of Astragalus granule of different dosages on quality of life in patients with chronic heart failure
2011 · moderate dosage · Patients with chronic heart failure and Fei-qi-deficiency and/or Xin-Shen yang-deficiency syndromes
9 g30 days30
Clinical effect of Astragalus granule of different dosages on quality of life in patients with chronic heart failure
2011 · low dosage · Patients with chronic heart failure and Fei-qi-deficiency and/or Xin-Shen yang-deficiency syndromes
4.5 g30 days30
[Effects of astragalus on cardiac function and serum tumor necrosis factor-alpha level in patients with chronic heart failure]
2010 · Chinese medicine (CM) group · Patients with chronic heart failure of Xin-qi deficiency or Xin-yang deficiency types
4.5 g2 weeks—
[Treatment of chronic primary glomerulopathy patients of Shen deficiency and dampness heat syndrome by yishen qingli granule combined low-dose Tripterygium wilfordii multiglycoside tablet: a clinical efficacy observation]
2013 · trial group · Adults with chronic primary glomerulopathy and Shen deficiency and dampness heat syndrome
20 g24 weeks115
Effects of huoxin formula on the arterial functions of patients with coronary heart disease
2019 · intervention group · Adults aged 18–75 with diagnosed coronary heart disease and stable angina pectoris; both sexes
9 g90 days30
Standardized astragalus extract for attenuation of the immunosuppression induced by strenuous physical exercise: randomized controlled trial
2021 · supplemented subgroup · Men aged 20–22 years who were members of the Polish Rowing Team and undergoing intensive training
1 g6 weeks10
Astragalus Membranaceus Improving Asymptomatic Left Ventricular Diastolic Dysfunction in Postmenopausal Hypertensive Women with Metabolic Syndrome: A Prospective, Open-Labeled, Randomized Controlled Trial
2018 · AM Group 2 · Postmenopausal women under 60 years old with hypertension, metabolic syndrome, and asymptomatic left ventricular diastolic dysfunction
10 g1 year53
Astragalus Membranaceus Improving Asymptomatic Left Ventricular Diastolic Dysfunction in Postmenopausal Hypertensive Women with Metabolic Syndrome: A Prospective, Open-Labeled, Randomized Controlled Trial
2018 · AM Group 1 · Postmenopausal women under 60 years old with hypertension, metabolic syndrome, and asymptomatic left ventricular diastolic dysfunction
5 g1 year49
TA-65, A Telomerase Activator improves Cardiovascular Markers in Patients with Metabolic Syndrome
2018 · TA-65 supplement · Patients with metabolic syndrome; age and sex not reported
16 mg12 weeks40
Astragalosides Supplementation Enhances Intrinsic Muscle Repair Capacity Following Eccentric Exercise-Induced Injury
2022 · Astragalosides supplementation · Recreationally active, healthy adult men with no history of regular resistance training; age range not reported.
4 mg7 days12
Aqueous extract of Astragali Radix induces human natriuresis through enhancement of renal response to atrial natriuretic peptide
2008 · Aqueous extract of Astragali Radix (ARE) · Healthy men
300 mg/kg1 day6
[Effects of Mongolia Astragali Radix in protecting early cardiac and nephritic functions of patients of hypertension with metabolic syndrome]
2016 · Astragali Radix group 1 · Adults older than 18 with essential hypertension and metabolic syndrome
10 g1 year—
[Effects of Mongolia Astragali Radix in protecting early cardiac and nephritic functions of patients of hypertension with metabolic syndrome]
2016 · Astragali Radix group 2 · Adults older than 18 with essential hypertension and metabolic syndrome
5 g1 year—
Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trial
2024 · Add-on oral astragalus granules · Adults with type 2 diabetes, stage 2 to 3 chronic kidney disease, and macroalbuminuria; eGFR 30–90 ml/min/1.73 m² and UACR 300–5000 mg/g
15 g48 weeks—
[Effects and Efficacy of Wenyang Huayin Yangxin Prescription on the Traditional Chinese Medicine Syndromes of Patients With Chronic Heart Failure Combined With Diuretic Resistance]
2025 · Observation group · Adults aged 40–80 with chronic heart failure, NYHA class III–IV, diuretic resistance, and the traditional Chinese medicine pattern of yang-qi deficiency, blood stasis, and phlegm-fluid retention
30 g2 weeks34
A Natural Astragalus-Based Nutritional Supplement Lengthens Telomeres in a Middle-Aged Population: A Randomized, Double-Blind, Placebo-Controlled Study
2024 · Group A (ASTCOQ02) · Healthy adult volunteers, mean age 55.8 years; 8 men and 12 women; no significant medical history
315 mg26 weeks20